Bioline Rx Ltd Ret. on equity
What is the Ret. on equity of Bioline Rx Ltd?
The Ret. on equity of Bioline Rx Ltd is -38.63%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Bioline Rx Ltd
What does Bioline Rx Ltd do?
biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m
Companies with ret. on equity similar to Bioline Rx Ltd
- WeTrade has Ret. on equity of -38.73%
- Sherpa II has Ret. on equity of -38.73%
- China Dredging Environment Protection has Ret. on equity of -38.72%
- Plexus plc has Ret. on equity of -38.71%
- Nephros has Ret. on equity of -38.64%
- Two Shields Investments Plc has Ret. on equity of -38.63%
- Bioline Rx Ltd has Ret. on equity of -38.63%
- Jindal Drilling & Industries has Ret. on equity of -38.60%
- Lipocine Inc has Ret. on equity of -38.58%
- Gores Metropoulos has Ret. on equity of -38.57%
- Melco International Development has Ret. on equity of -38.56%
- Farstarcap Investment has Ret. on equity of -38.55%
- DiaMedica Therapeutics has Ret. on equity of -38.54%